Breaking News
17 hours ago
Simantini Singh Deo

Cipla elevates Saurabh Gambhir to Chief Strategy Officer (Global), signalling a consolidation of strategic oversight across its international manufacturing and regulatory network.
Simantini Singh Deo

Sanofi names Paulo Fontoura EVP, Global Head of R&D Pharma, effective September 1, 2026, succeeding Dr. Houman Ashrafian.
Simantini Singh Deo

Boehringer Ingelheim opens three Phase III trials in SCLC, epNEC, and HER2-mutant NSCLC, advancing biomarker-driven oncology into late-stage development.
Simantini Singh Deo
Hetero promotes Sameer Garaye to VP of pharmaceutical R&D, signalling focus on advanced formulation development.
Vaibhavi M.
